Emergent BioSolutions, Inc. (EBS)

11.11 +0.12 (+1.09%) USD  |  NYSE  |  Feb 20, 13:42
More

Emergent BioSolutions Price Target Std Dev

Price Target Std Dev Chart

View Price Target Std Dev for EBS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price Target Std Dev Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Price Target Std Dev Range, Past 5 Years

View Price Target Std Dev Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price Target Std Dev Benchmarks

View Price Target Std Dev Benchmarks
Start Trial
Boston Scientific Corp. Upgrade
Eli Lilly & Co. Upgrade
Penumbra, Inc. Upgrade
Disc Medicine, Inc. Upgrade
MetaVia, Inc. Upgrade